Title: Tamura M, et, al. Development of specific Rho-kinase inhibitors and their clinical application. Biochim Biophys Acta. 2005 Dec 30; 1754(1-2): 245-52.
871543-07-6
1404437-50-8
451462-58-1
91348-51-5 | 1-(4-Bromophenyl)-5-oxopyrrolidine-3-carboxylic acid | AA006NOS | MFCD00448856
6623-81-0 | 5-Methoxyuracil | AA006OLO | MFCD03428618
96651-85-3 | 2,3-Dihydrospiro[indene-1,4'-piperidine] hydrochloride | AA006PJO | MFCD08461061
96440-78-7 | 3-tert-Butyl-1h-1,2,4-triazole | AA006QOY | MFCD11847493
96-27-5 | 3-Mercapto-1,2-propanediol | AA006RXK | MFCD00004879
947179-19-3 | tert-Butyl (4-(difluoromethyl)thiazol-2-yl)carbamate | AA006SYH | MFCD18833784
648423-85-2 | Imidazo[1,2-a]pyridine-7-carboxylic acid | AA006TLJ | MFCD09834781
152265-57-1 | 7-Bromophthalazin-1(2h)-one | AA006U8S | MFCD11518962
50332-66-6 | 4-Hydroxy-3-nitroquinoline | AA006UU2 | MFCD00277722
143328-19-2 | 1-(4-Bromophenyl)cyclopentanecarbonitrile | AA006V9E | MFCD01536834